{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:24:56Z","timestamp":1793021096073,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04477-4","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:57:38Z","timestamp":1763135858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antimicrobial resistance patterns and molecular characterization of Acinetobacter baumannii isolates in non-COVID-19 patients admitted to intensive care units during the pandemic: a retrospective study at a tertiary hospital in Tehran, Iran"],"prefix":"10.1186","volume":"25","author":[{"given":"Mahsa","family":"Ghamari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Jabalameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Emaneini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Beigverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"10","key":"4477_CR1","volume":"5","author":"M Hamidian","year":"2019","unstructured":"Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10):e000306.","journal-title":"Microb Genom"},{"issue":"10","key":"4477_CR2","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","volume":"48","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48(10):6987\u201398. https:\/\/doi.org\/10.1007\/s11033-021-06690-6.","journal-title":"Mol Biol Rep"},{"key":"4477_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9040205","author":"R V\u00e1zquez-L\u00f3pez","year":"2020","unstructured":"V\u00e1zquez-L\u00f3pez R, Solano-G\u00e1lvez SG, Ju\u00e1rez Vignon-Whaley JJ, Abello Vaamonde JA, Padr\u00f3 Alonzo LA, Rivera Res\u00e9ndiz A, et al. Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics. 2020. https:\/\/doi.org\/10.3390\/antibiotics9040205.","journal-title":"Antibiotics"},{"issue":"1","key":"4477_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1080\/22221751.2019.1698273","volume":"8","author":"O Ayobami","year":"2019","unstructured":"Ayobami O, Willrich N, Harder T, Okeke IN, Eckmanns T, Markwart R. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infect. 2019;8(1):1747\u201359. https:\/\/doi.org\/10.1080\/22221751.2019.1698273.","journal-title":"Emerg Microbes Infect"},{"key":"4477_CR5","unstructured":"Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"4477_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020127","author":"FP Nocera","year":"2021","unstructured":"Nocera FP, Attili AR, De Martino L. Acinetobacter baumannii: its clinical significance in human and veterinary medicine. Pathogens. 2021. https:\/\/doi.org\/10.3390\/pathogens10020127.","journal-title":"Pathogens"},{"issue":"12","key":"4477_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111367","volume":"27","author":"A Thacharodi","year":"2024","unstructured":"Thacharodi A, Vithlani A, Hassan S, Alqahtani A, Pugazhendhi A. Carbapenem-resistant Acinetobacter baumannii raises global alarm for new antibiotic regimens. iScience. 2024;27(12):111367. https:\/\/doi.org\/10.1016\/j.isci.2024.111367.","journal-title":"iScience"},{"issue":"8","key":"4477_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12275-016-6146-0","volume":"54","author":"Y Gong","year":"2016","unstructured":"Gong Y, Shen X, Huang G, Zhang C, Luo X, Yin S, et al. Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital. J Microbiol. 2016;54(8):551\u20138. https:\/\/doi.org\/10.1007\/s12275-016-6146-0.","journal-title":"J Microbiol"},{"issue":"3","key":"4477_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jiph.2023.01.004","volume":"16","author":"TA Hafiz","year":"2023","unstructured":"Hafiz TA, Alghamdi SS, Mubaraki MA, Alghamdi SSM, Alothaybi A, Aldawood E, et al. A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically ill patients: clinical and microbiological findings. J Infect Public Health. 2023;16(3):313\u20139. https:\/\/doi.org\/10.1016\/j.jiph.2023.01.004.","journal-title":"J Infect Public Health"},{"issue":"4","key":"4477_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4314\/ajcem.v24i4.13","volume":"24","author":"O Ogbonna","year":"2023","unstructured":"Ogbonna O, Onuoha S, David I, Ogbu O. Prevalence and phenotypic characteristics of Acinetobacter baumannii isolated from critically ill patients in two healthcare facilities in Ebonyi State, Nigeria. Afr J Clin Exp Microbiol. 2023;24(4):408\u201314. https:\/\/doi.org\/10.4314\/ajcem.v24i4.13.","journal-title":"Afr J Clin Exp Microbiol"},{"issue":"4","key":"4477_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.18683\/germs.2017.1126","volume":"7","author":"J Uwingabiye","year":"2017","unstructured":"Uwingabiye J, Lemnouer A, Baidoo S, Frikh M, Kasouati J, Maleb A, et al. Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome. Germs. 2017;7(4):193\u2013205. https:\/\/doi.org\/10.18683\/germs.2017.1126.","journal-title":"Germs"},{"key":"4477_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijregi.2023.10.007","volume":"9","author":"F Kipsang","year":"2023","unstructured":"Kipsang F, Munyiva J, Menza N, Musyoki A. Carbapenem-resistant Acinetobacter baumannii infections: antimicrobial resistance patterns and risk factors for acquisition in a Kenyan intensive care unit. IJID Reg. 2023;9:111\u20136. https:\/\/doi.org\/10.1016\/j.ijregi.2023.10.007.","journal-title":"IJID Reg"},{"key":"4477_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2147\/idr.S162232","volume":"11","author":"W Duszynska","year":"2018","unstructured":"Duszynska W, Litwin A, Rojek S, Szczesny A, Ciasullo A, Gozdzik W. Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study. Infect Drug Resist. 2018;11:629\u201335. https:\/\/doi.org\/10.2147\/idr.S162232.","journal-title":"Infect Drug Resist"},{"key":"4477_CR14","unstructured":"Organization WH. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. 2016:91."},{"issue":"9","key":"4477_CR15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1017\/ice.2022.288","volume":"44","author":"KJ Locey","year":"2023","unstructured":"Locey KJ, Webb TA, Weinstein RA, Hota B, Stein BD. Random variation drives a critical bias in the comparison of healthcare-associated infections. Infect Control Hosp Epidemiol. 2023;44(9):1396\u2013402. https:\/\/doi.org\/10.1017\/ice.2022.288.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"16","key":"4477_CR16","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574\u201381. https:\/\/doi.org\/10.1001\/jama.2020.5394.","journal-title":"JAMA"},{"key":"4477_CR17","unstructured":"Prevention CCfDCa: 2019 Antibiotic resistance threats report. 2019."},{"key":"4477_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107605","volume":"204","author":"R Sharma","year":"2025","unstructured":"Sharma R, Lakhanpal D. Acinetobacter baumannii: a comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies. Microb Pathog. 2025;204:107605.","journal-title":"Microb Pathog"},{"key":"4477_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211001144","volume":"9","author":"T Alotaibi","year":"2021","unstructured":"Alotaibi T, Abuhaimed A, Alshahrani M, Albdelhady A, Almubarak Y, Almasari O. Prevalence of multidrug-resistant Acinetobacter baumannii in a critical care setting: a tertiary teaching hospital experience. SAGE Open Med. 2021;9:20503121211001144. https:\/\/doi.org\/10.1177\/20503121211001144.","journal-title":"SAGE Open Med"},{"issue":"1","key":"4477_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14744\/cm.2023.57338","volume":"16","author":"K Arslan","year":"2024","unstructured":"Arslan K, \u015eahin AS. Clinical characteristics, antibiotic resistance profiles, and factors affecting mortality in patients isolated acinetobacter baumannii in intensive care unit: retrospective tertiary center analysis. Compr Med. 2024;16(1):51\u20137. https:\/\/doi.org\/10.14744\/cm.2023.57338.","journal-title":"Compr Med"},{"key":"4477_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14050490","author":"F Foglia","year":"2025","unstructured":"Foglia F, Ambrosino A, Bashir S, Finamore E, Zannella C, Donnarumma G, et al. Prevalence of acinetobacter baumannii multidrug resistance in university hospital environment. Antibiotics. 2025. https:\/\/doi.org\/10.3390\/antibiotics14050490.","journal-title":"Antibiotics"},{"key":"4477_CR22","doi-asserted-by":"publisher","unstructured":"Liu X, Qin P, Wen H, Wang W, Huo Q, Li Q, Zhao J. Sex differences in Acinetobacter baumannii infections: a comprehensive analysis of antibiotic resistance patterns in Hebei Province, China. Am J Infect Control. 2025.https:\/\/doi.org\/10.1016\/j.ajic.2025.07.011.","DOI":"10.1016\/j.ajic.2025.07.011"},{"key":"4477_CR23","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.2147\/idr.S423969","volume":"16","author":"H Song","year":"2023","unstructured":"Song H, Zhang H, Zhang D, Liu B, Wang P, Liu Y, et al. Establishment and validation of a risk prediction model for mortality in patients with Acinetobacter baumannii Infection: a retrospective study. Infect Drug Resist. 2023;16:7855\u201366. https:\/\/doi.org\/10.2147\/idr.S423969.","journal-title":"Infect Drug Resist"},{"key":"4477_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13030213","author":"L Abarca-Coloma","year":"2024","unstructured":"Abarca-Coloma L, Puga-Tejada M, Nu\u00f1ez-Quezada T, G\u00f3mez-Cruz O, Mawyin-Mu\u00f1oz C, Barungi S, et al. Risk factors associated with mortality in Acinetobacter baumannii infections: results of a prospective cohort study in a tertiary public hospital in Guayaquil, Ecuador. Antibiotics. 2024. https:\/\/doi.org\/10.3390\/antibiotics13030213.","journal-title":"Antibiotics"},{"issue":"1","key":"4477_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12941-019-0319-8","volume":"18","author":"B Boral","year":"2019","unstructured":"Boral B, Unaldi \u00d6, Ergin A, Durmaz R, Eser \u00d6K, Zarakolu P, et al. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features. Ann Clin Microbiol Antimicrob. 2019;18(1):19. https:\/\/doi.org\/10.1186\/s12941-019-0319-8.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"4477_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ejcdt.2017.01.003","volume":"66","author":"AE Sileem","year":"2017","unstructured":"Sileem AE, Said AM, Meleha MS. Acinetobacter baumannii in ICU patients: a prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality. Egypt J Chest Dis Tuberc. 2017;66(4):693\u20138. https:\/\/doi.org\/10.1016\/j.ejcdt.2017.01.003.","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"1","key":"4477_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-023-01343-8","volume":"12","author":"R Itani","year":"2023","unstructured":"Itani R, Khojah HMJ, Karout S, Rahme D, Hammoud L, Awad R, et al. Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon. Antimicrob Resist Infect Control. 2023;12(1):136. https:\/\/doi.org\/10.1186\/s13756-023-01343-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"4477_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ajic.2019.08.023","volume":"48","author":"VD Rosenthal","year":"2020","unstructured":"Rosenthal VD, Bat-Erdene I, Gupta D, Belkebir S, Rajhans P, Zand F, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012\u20132017: device-associated module. Am J Infect Control. 2020;48(4):423\u201332. https:\/\/doi.org\/10.1016\/j.ajic.2019.08.023.","journal-title":"Am J Infect Control"},{"issue":"5","key":"4477_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/s2213-2600(14)70061-x","volume":"2","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Marshall JC, Namendys-Silva SA, Fran\u00e7ois B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380\u20136. https:\/\/doi.org\/10.1016\/s2213-2600(14)70061-x.","journal-title":"Lancet Respir Med"},{"key":"4477_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131946","author":"MA Salam","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare. 2023. https:\/\/doi.org\/10.3390\/healthcare11131946.","journal-title":"Healthcare"},{"key":"4477_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030516","author":"K Novovi\u0107","year":"2023","unstructured":"Novovi\u0107 K, Jov\u010di\u0107 B. Colistin resistance in Acinetobacter baumannii: molecular mechanisms and epidemiology. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12030516.","journal-title":"Antibiotics"},{"issue":"3","key":"4477_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.105862","volume":"55","author":"S Gerson","year":"2020","unstructured":"Gerson S, Luca\u00dfen K, Wille J, Nodari CS, Stefanik D, Nowak J, et al. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii. Int J Antimicrob Agents. 2020;55(3):105862. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.105862.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"4477_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8020287","volume":"8","author":"G Papathanakos","year":"2020","unstructured":"Papathanakos G, Andrianopoulos I, Papathanasiou A, Priavali E, Koulenti D, Koulouras V. Colistin-resistant Acinetobacter baumannii bacteremia: a serious threat for critically ill patients. Microorganisms. 2020;8(2):287.","journal-title":"Microorganisms"},{"issue":"6","key":"4477_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/mdr.2019.0243","volume":"26","author":"IMS Al-Kadmy","year":"2020","unstructured":"Al-Kadmy IMS, Ibrahim SA, Al-Saryi N, Aziz SN, Besinis A, Hetta HF. Prevalence of genes involved in colistin resistance in acinetobacter baumannii: first report from Iraq. Microb Drug Resist. 2020;26(6):616\u201322. https:\/\/doi.org\/10.1089\/mdr.2019.0243.","journal-title":"Microb Drug Resist"},{"issue":"3","key":"4477_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.18502\/ijm.v16i3.15762","volume":"16","author":"G Rahimzadeh","year":"2024","unstructured":"Rahimzadeh G, Valadan R, Rezai S, Khosravi M, Vahedi Larijani L, Sheidaei S, et al. Evaluation of antibiotic resistance changes in Acinetobacter baumannii in the era of COVID-19 in Northern Iran. Iran J Microbiol. 2024;16(3):314\u201322. https:\/\/doi.org\/10.18502\/ijm.v16i3.15762.","journal-title":"Iran J Microbiol"},{"issue":"1","key":"4477_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00769-8","volume":"9","author":"B Lukovic","year":"2020","unstructured":"Lukovic B, Gajic I, Dimkic I, Kekic D, Zornic S, Pozder T, et al. The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates. Antimicrob Resist Infect Control. 2020;9(1):101. https:\/\/doi.org\/10.1186\/s13756-020-00769-8.","journal-title":"Antimicrob Resist Infect Control"},{"key":"4477_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.994303","volume":"13","author":"A Maleki","year":"2022","unstructured":"Maleki A, Kaviar VH, Koupaei M, Haddadi MH, Kalani BS, Valadbeigi H, et al. Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran. Front Microbiol. 2022;13:994303. https:\/\/doi.org\/10.3389\/fmicb.2022.994303.","journal-title":"Front Microbiol"},{"issue":"4","key":"4477_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12668-019-00658-4","volume":"9","author":"A Talebi Bezmin Abadi","year":"2019","unstructured":"Talebi Bezmin Abadi A, Rizvanov AA, Haertl\u00e9 T, Blatt NL. World health organization report: current crisis of antibiotic resistance. BioNanoScience. 2019;9(4):778\u201388. https:\/\/doi.org\/10.1007\/s12668-019-00658-4.","journal-title":"BioNanoScience"},{"key":"4477_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00668","volume":"11","author":"M Palmieri","year":"2020","unstructured":"Palmieri M, D\u2019Andrea MM, Pelegrin AC, Perrot N, Mirande C, Blanc B, et al. Abundance of colistin-resistant, OXA-23- and ArmA-producing Acinetobacter baumannii belonging to international clone 2 in Greece. Front Microbiol. 2020;11:668. https:\/\/doi.org\/10.3389\/fmicb.2020.00668.","journal-title":"Front Microbiol"},{"key":"4477_CR40","doi-asserted-by":"publisher","first-page":"1229473","DOI":"10.3389\/fcimb.2023.12294738","volume":"13","author":"MM Zafer","year":"2023","unstructured":"Zafer MM, Hussein AFA, Al-Agamy MH, Radwan HH, Hamed SM. Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons. Front Cell Infect Microbiol. 2023;13:1229473. https:\/\/doi.org\/10.3389\/fcimb.2023.12294738.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"4477_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251508","volume":"16","author":"RM Hassan","year":"2021","unstructured":"Hassan RM, Salem ST, Hassan SIM, Hegab AS, Elkholy YS. Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients. PLoS One. 2021;16(6):e0251508. https:\/\/doi.org\/10.1371\/journal.pone.0251508.","journal-title":"PLoS One"},{"issue":"4","key":"4477_CR42","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.113008","volume":"14","author":"N Zahra","year":"2021","unstructured":"Zahra N, Zeshan B, Qadri MMA, Ishaq M, Afzal M, Ahmed N. Phenotypic and genotypic evaluation of antibiotic resistance of Acinetobacter baumannii bacteria isolated from surgical intensive care unit patients in Pakistan. Jundishapur J Microbiol. 2021;14(4):e113008. https:\/\/doi.org\/10.5812\/jjm.113008.","journal-title":"Jundishapur J Microbiol"},{"issue":"3","key":"4477_CR43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.18502\/ijm.v13i3.6388","volume":"13","author":"A Vahhabi","year":"2021","unstructured":"Vahhabi A, Hasani A, Rezaee MA, Baradaran B, Hasani A, Kafil HS, et al. Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync. Iran J Microbiol. 2021;13(3):282\u201393. https:\/\/doi.org\/10.18502\/ijm.v13i3.6388.","journal-title":"Iran J Microbiol"},{"issue":"5","key":"4477_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/20477724.2020.1765124","volume":"114","author":"A Farajzadeh Sheikh","year":"2020","unstructured":"Farajzadeh Sheikh A, Savari M, Abbasi Montazeri E, Khoshnood S. Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in southwestern Iran. Pathog Glob Health. 2020;114(5):251\u201361. https:\/\/doi.org\/10.1080\/20477724.2020.1765124.","journal-title":"Pathog Glob Health"},{"issue":"2","key":"4477_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3947\/ic.2022.0022","volume":"54","author":"Z Hashemizadeh","year":"2022","unstructured":"Hashemizadeh Z, Hatam G, Fathi J, Aminazadeh F, Hosseini-Nave H, Hadadi M, et al. The spread of insertion sequences element and transposons in carbapenem resistant Acinetobacter baumannii in a hospital setting in southwestern Iran. Infect Chemother. 2022;54(2):275\u201386. https:\/\/doi.org\/10.3947\/ic.2022.0022.","journal-title":"Infect Chemother"},{"issue":"11","key":"4477_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.22038\/ijbms.2020.44853.10463","volume":"23","author":"L Azimi","year":"2020","unstructured":"Azimi L, Fallah F, Karimi A, Shirdoust M, Azimi T, Sedighi I, et al. Survey of various carbapenem-resistant mechanisms of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical samples in Iran. Iran J Basic Med Sci. 2020;23(11):1396\u2013400. https:\/\/doi.org\/10.22038\/ijbms.2020.44853.10463.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"4477_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1089\/mdr.2020.0106","volume":"27","author":"G Al-Hashem","year":"2021","unstructured":"Al-Hashem G, Rotimi VO, Albert MJ. Antimicrobial resistance of serial isolates of Acinetobacter baumannii colonizing the rectum of adult intensive care unit patients in a teaching hospital in Kuwait. Microb Drug Resist. 2021;27(1):64\u201372. https:\/\/doi.org\/10.1089\/mdr.2020.0106.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"4477_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317798","volume":"20","author":"Q Ababneh","year":"2025","unstructured":"Ababneh Q, Aldaken N, Jaradat Z, Al-Rousan E, Inaya Z, Alsaleh D, et al. Predominance of extensively-drug resistant Acinetobacter baumannii carrying bla OXA-23 in Jordanian patients admitted to the intensive care units. PLoS One. 2025;20(2):e0317798. https:\/\/doi.org\/10.1371\/journal.pone.0317798.","journal-title":"PLoS One"},{"issue":"4","key":"4477_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102695","volume":"18","author":"FA Alanazi","year":"2025","unstructured":"Alanazi FA, Almaary KS, Dawoud TM, El-Tayeb MA, Elbadawi YB, Mubarak AS, et al. Molecular characterization of putative antibiotic resistance determinant and virulence factors genes of Acinetobacter baumannii strains isolated from intensive care unit patients in Riyadh, Saudi Arabia. J Infect Public Health. 2025;18(4):102695. https:\/\/doi.org\/10.1016\/j.jiph.2025.102695.","journal-title":"J Infect Public Health"},{"key":"4477_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnac100","author":"M Ghamari","year":"2022","unstructured":"Ghamari M, Beigverdi R, Jabalameli F, Emaneini M. Antimicrobial resistance pattern, virulence determinants and molecular analysis of carbapenem-resistant Klebsiella pneumoniae isolated from clinical samples in Iran. FEMS Microbiol Lett. 2022. https:\/\/doi.org\/10.1093\/femsle\/fnac100.","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"4477_CR51","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/jac\/dku045","volume":"69","author":"Z Hojabri","year":"2014","unstructured":"Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A, Mammina C. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J Antimicrob Chemother. 2014;69(9):2383\u20137. https:\/\/doi.org\/10.1093\/jac\/dku045.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4477_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jiph.2015.04.030","volume":"8","author":"S Mahdian","year":"2015","unstructured":"Mahdian S, Sadeghifard N, Pakzad I, Ghanbari F, Soroush S, Azimi L, et al. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-\u03b2-lactamase genes are widespread among hospitalized burn patients in Tehran. J Infect Public Health. 2015;8(6):533\u201342. https:\/\/doi.org\/10.1016\/j.jiph.2015.04.030.","journal-title":"J Infect Public Health"},{"key":"4477_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1172861","volume":"14","author":"G Naderi","year":"2023","unstructured":"Naderi G, Talebi M, Gheybizadeh R, Seifi A, Ghourchian S, Rahbar M, et al. Mobile genetic elements carrying aminoglycoside resistance genes in Acinetobacter baumannii isolates belonging to global clone 2. Front Microbiol. 2023;14:1172861. https:\/\/doi.org\/10.3389\/fmicb.2023.1172861.","journal-title":"Front Microbiol"},{"issue":"2","key":"4477_CR54","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijmmb.2021.03.005","volume":"39","author":"ND Nogbou","year":"2021","unstructured":"Nogbou ND, Phofa DT, Nchabeleng M, Musyoki AM. Investigating multi-drug resistant Acinetobacter baumannii isolates at a tertiary hospital in Pretoria, South Africa. Indian J Med Microbiol. 2021;39(2):218\u201323. https:\/\/doi.org\/10.1016\/j.ijmmb.2021.03.005.","journal-title":"Indian J Med Microbiol"},{"issue":"5","key":"4477_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.18502\/ijm.v15i5.13871","volume":"15","author":"AA Al Jebur","year":"2023","unstructured":"Al Jebur AA, Soleimani N, Hosseini SM. Comparison of loop-mediated isothermal amplification, multiplex PCR, and REP- PCR techniques for identification of carbapenem-resistant Acinetobacter baumannii clinical isolates. Iran J Microbiol. 2023;15(5):654\u201364. https:\/\/doi.org\/10.18502\/ijm.v15i5.13871.","journal-title":"Iran J Microbiol"},{"issue":"5","key":"4477_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/mdr.2016.0130","volume":"23","author":"S Biglari","year":"2017","unstructured":"Biglari S, Hanafiah A, Mohd Puzi S, Ramli R, Rahman M, Lopes BS. Antimicrobial resistance mechanisms and genetic diversity of multidrug-resistant Acinetobacter baumannii isolated from a teaching hospital in Malaysia. Microb Drug Resist. 2017;23(5):545\u201355. https:\/\/doi.org\/10.1089\/mdr.2016.0130.","journal-title":"Microb Drug Resist"},{"key":"4477_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drup.2018.10.003","volume":"41","author":"M Hamidian","year":"2018","unstructured":"Hamidian M, Hall RM. The abar antibiotic resistance islands found in Acinetobacter baumannii global clone 1 - structure, origin and evolution. Drug Resist Updat. 2018;41:26\u201339. https:\/\/doi.org\/10.1016\/j.drup.2018.10.003.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"4477_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11169-x","volume":"25","author":"FM Adeyemi","year":"2025","unstructured":"Adeyemi FM, Akinlade EA, Yusuf-Omoloye NA, Ajigbewu OH, Dare AP, Wahab AA, et al. Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains. BMC Infect Dis. 2025;25(1):786. https:\/\/doi.org\/10.1186\/s12879-025-11169-x.","journal-title":"BMC Infect Dis"},{"key":"4477_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mimet.2014.10.001","volume":"107","author":"YP Wong","year":"2014","unstructured":"Wong YP, Chua KH, Thong KL. One-step species-specific high resolution melting analysis for nosocomial bacteria detection. J Microbiol Methods. 2014;107:133\u20137. https:\/\/doi.org\/10.1016\/j.mimet.2014.10.001.","journal-title":"J Microbiol Methods"},{"key":"4477_CR60","unstructured":"Weinstein MP LB, Patel J, Mathers A, Campeau S, Mazzulli T, et al. CLSI supplement M100. Clinical and Laboratory Standards Institute. 32rd edn. Philadelphia, United States; 2022."},{"issue":"3","key":"4477_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030373","volume":"10","author":"I Kyriakidis","year":"2021","unstructured":"Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;10(3):373. https:\/\/doi.org\/10.3390\/pathogens10030373.","journal-title":"Pathogens"},{"key":"4477_CR62","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fcimb.2024.1298202","volume":"14","author":"X Jian","year":"2024","unstructured":"Jian X, Li Y, Wang H, Li C, Li F, Li J, et al. A comparative study of genotyping and antimicrobial resistance between carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates at a tertiary pediatric hospital in China. Front Cell Infect Microbiol. 2024;14:2024. https:\/\/doi.org\/10.3389\/fcimb.2024.1298202.","journal-title":"Front Cell Infect Microbiol."},{"issue":"1","key":"4477_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-024-00668-5","volume":"23","author":"N Ahmadi","year":"2024","unstructured":"Ahmadi N, Salimizand H, Zomorodi AR, Abbas JE, Ramazanzadeh R, Haghi F, et al. Genomic diversity of \u03b2-lactamase producing Pseudomonas aeruginosa in Iran; the impact of global high-risk clones. Ann Clin Microbiol Antimicrob. 2024;23(1):5. https:\/\/doi.org\/10.1186\/s12941-024-00668-5.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"4477_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14070693","volume":"14","author":"MMS Saraiva","year":"2025","unstructured":"Saraiva MMS, Rodrigues HLDS, Benevides VP, de Leon CMCG, Santos SCL, Stipp DT, et al. Antimicrobial resistance patterns of staphylococcus aureus cultured from the healthy horses\u2019 nostrils sampled in distant regions of Brazil. Antibiotics. 2025;14(7):693.","journal-title":"Antibiotics"},{"key":"4477_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1620479","volume":"15","author":"S S\u00e1nchez-Urtaza","year":"2025","unstructured":"S\u00e1nchez-Urtaza S, Alfonso-Alarc\u00f3n L, Arazo Del Pino R, Burgwinkel T, Ocampo-Sosa A, Gonzalez R, et al. Genomic characterization of multidrug-resistant clinical Acinetobacter baumannii isolates from a hospital in Paraguay. Front Cell Infect Microbiol. 2025;15:1620479. https:\/\/doi.org\/10.3389\/fcimb.2025.1620479.","journal-title":"Front Cell Infect Microbiol"},{"key":"4477_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.784130","volume":"12","author":"S Pourajam","year":"2022","unstructured":"Pourajam S, Kalantari E, Talebzadeh H, Mellali H, Sami R, Soltaninejad F, et al. Secondary bacterial infection and clinical characteristics in patients with COVID-19 admitted to two intensive care units of an academic hospital in Iran during the first wave of the pandemic. Front Cell Infect Microbiol. 2022;12:784130. https:\/\/doi.org\/10.3389\/fcimb.2022.784130.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4477_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11351-1","volume":"25","author":"MI Mike-Ogburia","year":"2025","unstructured":"Mike-Ogburia MI, Monsi TP, Nwokah EG. Prevalence and determinants of multidrug-resistant uropathogenic Klebsiella species and associated antimicrobial resistance genes in Port Harcourt, Nigeria. BMC Infect Dis. 2025;25(1):1036. https:\/\/doi.org\/10.1186\/s12879-025-11351-1.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4477_CR68","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/microbiolres14030083","volume":"14","author":"SS Sobieh","year":"2023","unstructured":"Sobieh SS, Mohamed SAH, El-Sayed MA, Abdallah SA. Molecular assessment of MCR-1 gene among pandrug-resistant Acinetobacter baumannii. Microbiol Res. 2023;14(3):1238\u201351.","journal-title":"Microbiol Res"},{"issue":"2","key":"4477_CR69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.18502\/ijm.v16i2.15351","volume":"16","author":"M Ghamari","year":"2024","unstructured":"Ghamari M, Emaneini M, Hemmati S, Jabalameli F, Beigverdi R. Phenotypic and genotypic evaluation of aminoglycoside resistance in Escherichia coli isolated from patients with blood stream infections in Tehran. Iran. Iran J Microbiol. 2024;16(2):187\u201392. https:\/\/doi.org\/10.18502\/ijm.v16i2.15351.","journal-title":"Iran J Microbiol"},{"issue":"1","key":"4477_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03301-9","volume":"24","author":"R Baral","year":"2024","unstructured":"Baral R, Tuladhar R, Manandhar S, Singh A, Sherchan S. Detection of blaKPC gene among carbapenemase producing Klebsiella pneumoniae isolated from different clinical specimens at tertiary care hospital of Nepal. BMC Microbiol. 2024;24(1):144. https:\/\/doi.org\/10.1186\/s12866-024-03301-9.","journal-title":"BMC Microbiol"},{"issue":"1","key":"4477_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10096-024-04974-w","volume":"44","author":"K Novovi\u0107","year":"2025","unstructured":"Novovi\u0107 K, Radovanovi\u0107 M, Gaji\u0107 I, Vasiljevi\u0107 Z, Male\u0161evi\u0107 M, \u0160api\u0107 K, et al. AdeABC, AdeFGH, and AdeIJK efflux pumps as key factors in tigecycline resistance of Acinetobacter baumannii: a study from Western Balkan hospitals. Eur J Clin Microbiol Infect Dis. 2025;44(1):129\u201342. https:\/\/doi.org\/10.1007\/s10096-024-04974-w.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4477_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-12-21","volume":"12","author":"CH Chen","year":"2013","unstructured":"Chen CH, Huang CC. Molecular epidemiological study of clinical Acinetobacter baumannii isolates: phenotype switching of antibiotic resistance. Ann Clin Microbiol Antimicrob. 2013;12:21. https:\/\/doi.org\/10.1186\/1476-0711-12-21.","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04477-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04477-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04477-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:57:40Z","timestamp":1763135860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04477-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4477"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04477-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran (approval code: IR.TUMS.MEDICINE.REC.1400.912). Sampling and data collection were conducted in accordance with the committee\u2019s regulations and ethical standards. The Ethics Committee of Tehran University of Medical Sciences reviewed the study and waived the requirement for informed consent, as it was a retrospective analysis involving only anonymized bacterial isolates and did not include any direct human participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate declaration"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"741"}}